Incannex Healthcare Financials
IXHL Stock | USD 1.98 0.01 0.51% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 2.74 | 2.8829 |
|
|
The financial analysis of Incannex Healthcare is a critical element in measuring its lifeblood. Investors should not minimize Incannex Healthcare's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Incannex | Select Account or Indicator |
Understanding current and past Incannex Healthcare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Incannex Healthcare's financial statements are interrelated, with each one affecting the others. For example, an increase in Incannex Healthcare's assets may result in an increase in income on the income statement.
Incannex Healthcare Stock Summary
Incannex Healthcare competes with Eliem Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies in Australia. Incannex Healthcare Limited was incorporated in 2001 and is based in Melbourne, Australia. Incannex Healthcare is traded on NASDAQ Exchange in the United States.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US45333L1061 |
CUSIP | 45333F109 45333L106 |
Location | Australia |
Business Address | 8 Century Circuit, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.incannex.com |
Phone | 61 4 0984 0786 |
Currency | USD - US Dollar |
Incannex Healthcare Key Financial Ratios
Return On Equity | -1.15 | ||||
Operating Margin | (538.33) % | ||||
Price To Sales | 2,904 X | ||||
Revenue | 12 K | ||||
Gross Profit | 1.01 M |
Incannex Healthcare Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.9M | 7.0M | 26.1M | 58.6M | 17.0M | 14.6M | |
Other Current Liab | 330.9K | 392.1K | 1.1M | 1.9M | 4.8M | 5.1M | |
Net Debt | (2.5M) | (6.9M) | (25.8M) | (21.6M) | (5.5M) | (5.2M) | |
Retained Earnings | (22.3M) | (33.0M) | (40.4M) | (52.1M) | (110.7M) | (105.1M) | |
Accounts Payable | 405.5K | 175.1K | 894.8K | 1.8M | 527K | 528.0K | |
Cash | 2.5M | 6.9M | 25.8M | 22.1M | 5.9M | 4.5M | |
Net Receivables | 284.0K | 127.0K | 219.3K | 256.5K | 10.0M | 10.5M | |
Total Liab | 736.4K | 567.3K | 1.4M | 3.0M | 5.8M | 6.1M | |
Total Current Assets | 2.9M | 7.0M | 26.1M | 23.0M | 16.2M | 17.0M | |
Common Stock | 23.5M | 34.5M | 59.6M | 99.8M | 2K | 1.9K | |
Other Current Assets | 17.3K | 36.1K | 419.8K | 1.7M | 10.7M | 11.2M | |
Inventory | 125.9K | (178.1K) | (337.5K) | (416.2K) | (10.0M) | (9.5M) | |
Net Tangible Assets | 3.2M | 8.6M | 35.9M | 31.4M | 36.1M | 37.9M | |
Net Invested Capital | 3.2M | 8.6M | 52.1M | 84.1M | 11.2M | 10.7M | |
Net Working Capital | 3.2M | 8.6M | 52.1M | 30.8M | 10.6M | 16.4M | |
Capital Stock | 34.2M | 45.9M | 125.9M | 150.8M | 2K | 1.9K |
Incannex Healthcare Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 85.1K | 4.5K | 2.7K | 6.3K | 5.6K | 5.4K | |
Operating Income | (2.9M) | (8.2M) | (11.4M) | (17.7M) | (30.0M) | (28.5M) | |
Ebit | (2.9M) | (8.2M) | (14.9M) | (20.5M) | (18.6M) | (17.7M) | |
Ebitda | (2.8M) | (8.2M) | (3.6M) | (20.4M) | (18.5M) | (17.6M) | |
Income Before Tax | (2.7M) | (8.2M) | (14.9M) | (20.0M) | (18.4M) | (17.5M) | |
Net Income | (3.2M) | (8.2M) | (14.9M) | (20.0M) | (18.5M) | (17.5M) | |
Income Tax Expense | 488.3K | (2.7K) | (3.6M) | 30K | 27K | 28.4K | |
Total Revenue | 415.6K | 1.9M | 782.4K | 1.0M | 12K | 11.4K | |
Gross Profit | 106.2K | 985.6K | 776.0K | 1.0M | 12K | 11.4K | |
Cost Of Revenue | 524.1K | 582.2K | 309.4K | 912.0K | 6.3K | 0.0 | |
Net Interest Income | 4.5K | 2.7K | 9.1K | 362.8K | 206K | 216.3K | |
Interest Income | 4.5K | 2.7K | 9.1K | 362.8K | 206K | 216.3K |
Incannex Healthcare Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | 2.4M | 4.1M | 19.5M | (2.7M) | (16.3M) | (15.4M) | |
Free Cash Flow | (3.9M) | (5.2M) | (8.8M) | (10.9M) | (16.1M) | (15.3M) | |
Other Non Cash Items | 598.0K | 2.9M | (408.9K) | (4.3K) | 7.8M | 4.6M | |
Capital Expenditures | 47.6K | 24.4K | 476.9K | 315.7K | 277K | 277.9K | |
Net Income | (4.7M) | (8.5M) | (10.3M) | (13.2M) | (18.5M) | (17.5M) | |
End Period Cash Flow | 2.5M | 6.9M | 25.8M | 22.1M | 5.9M | 4.5M | |
Investments | 13K | 29.3K | 0.0 | (476.9K) | (277K) | (263.2K) | |
Change To Netincome | 699.2K | 4.5M | 870.2K | 3.2M | 3.7M | 1.8M |
Incannex Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Incannex Healthcare's current stock value. Our valuation model uses many indicators to compare Incannex Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Incannex Healthcare competition to find correlations between indicators driving Incannex Healthcare's intrinsic value. More Info.Incannex Healthcare Ltd is rated second overall in return on equity category among its peers. It is rated fifth overall in return on asset category among its peers . At this time, Incannex Healthcare's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Incannex Healthcare by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Incannex Healthcare Systematic Risk
Incannex Healthcare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Incannex Healthcare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Incannex Healthcare correlated with the market. If Beta is less than 0 Incannex Healthcare generally moves in the opposite direction as compared to the market. If Incannex Healthcare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Incannex Healthcare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Incannex Healthcare is generally in the same direction as the market. If Beta > 1 Incannex Healthcare moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Incannex Healthcare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Incannex Healthcare's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Incannex Healthcare growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Incannex Healthcare November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Incannex Healthcare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Incannex Healthcare Ltd. We use our internally-developed statistical techniques to arrive at the intrinsic value of Incannex Healthcare Ltd based on widely used predictive technical indicators. In general, we focus on analyzing Incannex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Incannex Healthcare's daily price indicators and compare them against related drivers.
Downside Deviation | 6.17 | |||
Information Ratio | 0.0376 | |||
Maximum Drawdown | 28.99 | |||
Value At Risk | (10.66) | |||
Potential Upside | 10.05 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incannex Healthcare Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. If investors know Incannex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incannex Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.36) | Revenue Per Share 0.001 | Quarterly Revenue Growth 0.296 | Return On Assets (0.57) | Return On Equity (1.15) |
The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incannex Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.